All In MedTech

Device Trial Radar · NCT00791128

Study for Pre-Surgical Weight Loss in Type II Diabetes Patients

A Phase II Single-Center, Prospective, Open Label Study of Safety and Efficacy, of the GI Sleeve for Pre-Surgical Weight Loss, in Type II Diabetes Patients (Cohort 06-6B Only)

Last checked: Nov 20, 2026Latest source record: Jun 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

22

Actual

Start

Oct 2008

Primary completion

Mar 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Morphic Medical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 14, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the GI Sleeve is safe and effective in treating Type II diabetes patients

Conditions

  • Type 2 Diabetes
  • Obesity

Interventions

  • GI LinerDevice

    Medical device placed endoscopically in the duodenum, nutritional counseling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. % of Excess Weight Loss (EWL)Time frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr. Eduardo Guimaraes Hourneauz de Moura

    São Paulo, São Paulo, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.